Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, pleas
Oui — Apellis Pharmaceuticals a actuellement 15 offres ouvertes sur JobsRadar, réparties sur 3 services et 5 sites. 2 d’entre elles ont été publiées ces 30 derniers jours. 11 d’entre elles indiquent le salaire, avec une médiane de $169,000 par an. Dernière mise à jour le 28 octobre 2026 à 09:09 UTC.